Literature DB >> 14981670

Committee for Proprietary Medicinal Products (CPMP): points to consider on adjustment for baseline covariates.

.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 14981670     DOI： 10.1002/sim.1647

Source DB:  PubMed          Journal:  Stat Med        ISSN： 0277-6715            Impact factor:   2.373


× No keyword cloud information.
  46 in total

1.  Estimation of treatment effects based on possibly misspecified Cox regression.

Authors:  Satoshi Hattori; Masayuki Henmi
Journal:  Lifetime Data Anal       Date:  2012-04-21       Impact factor: 1.588

2.  Assessment of QT(c)-prolonging potential of BX471 in healthy volunteers. A 'thorough QT study' following ICH E14 using various QT(c) correction methods.

Authors:  Marc Vandemeulebroecke; Jürgen Lembcke; Herbert Wiesinger; Wolfgang Sittner; Stefanie Lindemann
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

3.  Positive Psychotherapy for Smoking Cessation: A Pilot Randomized Controlled Trial.

Authors:  Christopher W Kahler; Nichea S Spillane; Anne M Day; Patricia A Cioe; Acacia Parks; Adam M Leventhal; Richard A Brown
Journal:  Nicotine Tob Res       Date:  2015-02-02       Impact factor: 4.244

4.  Randomization in clinical trials: stratification or minimization? The HERMES free simulation software.

Authors:  Hélène Fron Chabouis; Francis Chabouis; Florence Gillaizeau; Pierre Durieux; Gilles Chatellier; N Dorin Ruse; Jean-Pierre Attal
Journal:  Clin Oral Investig       Date:  2013-03-01       Impact factor: 3.573

5.  Comments on tegaserod trial on irritable bowel syndrome.

Authors:  Hye-Kyung Jung
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

6.  Reply.

Authors:  Yong Sung Kim; Suck Chei Choi
Journal:  J Neurogastroenterol Motil       Date:  2010-04-28       Impact factor: 4.924

Review 7.  Reporting on covariate adjustment in randomised controlled trials before and after revision of the 2001 CONSORT statement: a literature review.

Authors:  Ly-Mee Yu; An-Wen Chan; Sally Hopewell; Jonathan J Deeks; Douglas G Altman
Journal:  Trials       Date:  2010-05-18       Impact factor: 2.279

8.  Fluoroscopy and imageless navigation enable an equivalent reconstruction of leg length and global and femoral offset in THA.

Authors:  Markus Weber; Michael Woerner; Robert Springorum; Ernst Sendtner; Alexander Hapfelmeier; Joachim Grifka; Tobias Renkawitz
Journal:  Clin Orthop Relat Res       Date:  2014-06-26       Impact factor: 4.176

9.  Explicit consideration of baseline factors to assess recombinant tissue-type plasminogen activator response with respect to race and sex.

Authors:  Pitchaiah Mandava; Santosh B Murthy; Melody Munoz; Dawn McGuire; Roger P Simon; Andrei V Alexandrov; Karen C Albright; Amelia K Boehme; Sheryl Martin-Schild; Sharyl Martini; Thomas A Kent
Journal:  Stroke       Date:  2013-05-14       Impact factor: 7.914

10.  Rationale and Design of the Randomized Evaluation of Default Access to Palliative Services (REDAPS) Trial.

Authors:  Katherine R Courtright; Vanessa Madden; Nicole B Gabler; Elizabeth Cooney; Dylan S Small; Andrea Troxel; David Casarett; Mary Ersek; J Brian Cassel; Lauren Hersch Nicholas; Gabriel Escobar; Sarah H Hill; Dan O'Brien; Mark Vogel; Scott D Halpern
Journal:  Ann Am Thorac Soc       Date:  2016-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.